Enfusion Announces First Quarter 2024 Results
NEW YORK & LONDON & HONG KONG–(BUSINESS WIRE)–Enfusion, Inc. (“Enfusion”) (NYSE: ENFN), a leading provider of software-as-a-service... Read more.
Priority Technology Holdings, Inc. Announces First Quarter Financial Results
Strong First Quarter Growth Driven by Performance Across Unified Commerce Platform ALPHARETTA, Ga.–(BUSINESS WIRE)–Priority Technology Holdings, Inc.... Read more.
Tokens.com Reports Financial Results for Q2 2024
TORONTO–(BUSINESS WIRE)–Tokens.com Corp. (TSX-V: COIN)(Frankfurt Stock Exchange: 76M) (OTCQB US: SMURF) (“Tokens.com” or the “Company”), a technology... Read more.
NETSCOUT Reports Fourth Quarter and Full Fiscal Year 2024 Financial Results
WESTFORD, Mass.–(BUSINESS WIRE)–NETSCOUT SYSTEMS, INC. (NASDAQ: NTCT), a leading provider of performance management, cybersecurity, and DDoS protection... Read more.
Vecima and VECTOR TECH SOLUTIONS Secure Entra® DAA Launching Point with ASTA-NET in Poland
VICTORIA, British Columbia–(BUSINESS WIRE)–Vecima Networks Inc. (TSX: VCM) today announced that VECTOR TECH SOLUTIONS is deploying Vecima’s Entra®... Read more.
Cresco Labs Announces May Conference Participation
CHICAGO–(BUSINESS WIRE)–Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products... Read more.
Nuveen Churchill Direct Lending Corp. Announces First Quarter 2024 Results
Reports Net Investment Income of $0.56 per Share Declares Second Quarter Regular Distribution of $0.45 per Share NEW YORK–(BUSINESS WIRE)–Nuveen Churchill... Read more.
Anumana’s ECG-AI™ Algorithms Honored with 2024 MedTech Breakthrough Award for “Best New Technology Solution-Cardiology”
Anumana’s innovative AI algorithms recognized for their transformative potential in cardiology – the first of which is now commercially available CAMBRIDGE,... Read more.
Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook
CLEARWATER, Fla.–(BUSINESS WIRE)–Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium... Read more.
PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting
SPT-300 demonstrated nine times greater allopregnanolone exposure in humans dosed orally than published data for oral allopregnanolone,1 validating Glyph™ platform’s... Read more.